Breast cancer chemoprevention by dietary natural phenolic compounds: Specific epigenetic related molecular targets

Molecular Nutrition and Food Research

Volumn 59, Issue 1, 2015, Pages 21-35

  Pan, Min Hsiung ^a,b   Chiou, Yi Siou ^a   Chen, Li Hua ^a   Ho, Chi Tang ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Breast cancer; Carcinogenesis; Chemoprevention; Epigenetics; Phenolic compounds

Indexed keywords

ANTINEOPLASTIC AGENT; PHENOL DERIVATIVE;

BREAST NEOPLASMS; CHEMISTRY; CHEMOPROPHYLAXIS; DRUG DELIVERY SYSTEM; FEMALE; GENETIC EPIGENESIS; HUMAN; PROCEDURES; SIGNAL TRANSDUCTION;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CHEMOPREVENTION; DRUG DELIVERY SYSTEMS; EPIGENESIS, GENETIC; FEMALE; HUMANS; PHENOLS; SIGNAL TRANSDUCTION;

EID: 84921303988     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400515     Document Type: Review

References (105)

1. Cipollini, G., Tommasi, S., Paradiso, A., Aretini, P. et al., Genetic alterations in hereditary breast cancer. Ann. Oncol. 2004, 15(Suppl 1), I7-I13.
2. Vanden, B. W., Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. Pharmacol. Res. 2012, 65, 565-576.
3. Jenkins, S., Betancourt, A. M., Wang, J., Lamartiniere, C. A., Endocrine-active chemicals in mammary cancer causation and prevention. J. Steroid Biochem. Mol. Biol. 2012, 129, 191-200.
4. Cristofanilli, M., Hortobagyi, G. N., Molecular targets in breast cancer: current status and future directions. Endocr. Relat. Cancer 2002, 9, 249-266.
5. Ahmad, A., Pathways to breast cancer recurrence. ISRN Oncol. 2013, 2013, 290568-290583.
6. Vera-Ramirez, L., Sanchez-Rovira, P., Ramirez-Tortosa, C. L., Quiles, J. L. et al., Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: latest advances towards an integrated approach. Cancer Treat. Rev. 2010, 36, 477-484.
7. Place, A. E., Jin, H. S., Polyak, K., The microenvironment in breast cancer progression: biology and implications for treatment. Breast Cancer Res. 2011, 13, 227-237.
8. Wu, C. H., Lee, C. H., Ho, Y. S., Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy. Clin. Cancer Res. 2011, 17, 3533-3541.
9. Sawan, C., Vaissiere, T., Murr, R., Herceg, Z., Epigenetic drivers and genetic passengers on the road to cancer. Mutat. Res. 2008, 642, 1-13.
10. Cazzaniga, M., Bonanni, B., Breast cancer chemoprevention: old and new approaches. J. Biomed. Biotechnol. 2012, 2012, 985620-985634.
11. Langner, E., Rzeski, W., Dietary derived compounds in cancer chemoprevention. Contemp. Oncol. 2012, 16, 394-400.
12. Aiyer, H. S., Warri, A. M., Woode, D. R., Hilakivi-Clarke, L. et al., Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention. J. Agric. Food Chem. 2012, 60, 5693-5708.
13. Tan, K. W., Li, Y., Paxton, J. W., Birch, N. P. et al., Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Food Chem. 2013, 138, 2267-2274.
14. An, G., Gallegos, J., Morris, M. E., The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux. Drug Metab. Dispos. 2011, 39, 426-432.
15. Zhang, S., Yang, X., Morris, M. E., Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol. Pharmacol. 2004, 65, 1208-1216.
16. Dreiseitel, A., Oosterhuis, B., Vukman, K. V., Schreier, P. et al., Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1. Br. J. Pharmacol. 2009, 158, 1942-1950.
17. Li, Y., Meeran, S. M., Patel, S. N., Chen, H. et al., Epigenetic reactivation of estrogen receptor-alpha (ERalpha) by genistein enhances hormonal therapy sensitivity in ERalpha-negative breast cancer. Mol. Cancer 2013, 12, 9-25.
18. Farabegoli, F., Papi, A., Bartolini, G., Ostan, R. et al., (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine 2010, 17, 356-362.
19. Johnson, J. J., Bailey, H. H., Mukhtar, H., Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 2010, 17, 3-13.
20. Tome-Carneiro, J., Larrosa, M., Gonzalez-Sarrias, A., Tomas-Barberan, F. A. et al., Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr. Pharm. Des 2013, 19, 6064-6093.
21. Mittal, A., Piyathilake, C., Hara, Y., Katiyar, S. K., Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 2003, 5, 555-565.
22. Yang, C. S., Sang, S., Lambert, J. D., Lee, M. J., Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol. Nutr. Food Res. 2008, 52(Suppl 1), S139-S151.
23. Yun, S., Habicht, J. P., Miller, D. D., Glahn, R. P., An in vitro digestion/Caco-2 cell culture system accurately predicts the effects of ascorbic acid and polyphenolic compounds on iron bioavailability in humans. J. Nutr. 2004, 134, 2717-2721.
24. Amiot, M. J., Romier, B., Dao, T. M., Fanciullino, R. et al., Optimization of trans-resveratrol bioavailability for human therapy. Biochimie 2013, 95, 1233-1238.
25. Rice, S., Whitehead, S. A., Phytoestrogens and breast cancer-promoters or protectors? Endocr. Relat. Cancer 2006, 13, 995-1015.
26. Pan, M. H., Lai, C. S., Ho, C. T., Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010, 1, 15-31.
27. Schiff, R., Massarweh, S., Shou, J., Osborne, C. K., Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin. Cancer Res. 2003, 9, 447S-454S.
28. Matthews, J., Gustafsson, J. A., Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl. Recept. Signal. 2006, 4, e016.
29. Tan, B. S., Kang, O., Mai, C. W., Tiong, K. H. et al., 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor gamma (PPARgamma). Cancer Lett. 2013, 336, 127-139.
30. Li, F., Ye, L., Lin, S. M., Leung, L. K., Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7. Mol. Cell Endocrinol. 2011, 344, 51-58.
31. Wang, L. M., Xie, K. P., Huo, H. N., Shang, F. et al., Luteolin inhibits proliferation induced by IGF-1 pathway dependent ERalpha in human breast cancer MCF-7 cells. Asian Pac. J. Cancer Prev. 2012, 13, 1431-1437.
32. Nordeen, S. K., Bona, B. J., Jones, D. N., Lambert, J. R. et al., Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin. Horm. Cancer 2013, 4, 293-300.
33. Resende, F. A., de Oliveira, A. P., de Camargo, M. S., Vilegas, W. et al., Evaluation of estrogenic potential of flavonoids using a recombinant yeast strain and MCF7/BUS cell proliferation assay. PLoS One 2013, 8, e74881.
34. Chen, J., Zhao, X., Ye, Y., Wang, Y. et al., Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin. Cell Physiol. Biochem. 2013, 32, 1790-1797.
35. Chen, J., Hou, R., Zhang, X., Ye, Y. et al., Calycosin suppresses breast cancer cell growth via ERbeta-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways. PLoS One 2014, 9, e91245.
36. Stroheker, T., Picard, K., Lhuguenot, J. C., Canivenc-Lavier, M. C. et al., Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines. Food Chem. Toxicol. 2004, 42, 887-897.
37. Pons, D. G., Nadal-Serrano, M., Blanquer-Rossello, M. M., Sastre-Serra, J. et al., Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. J. Cell Biochem. 2014, 115, 949-958.
38. Nadal-Serrano, M., Pons, D. G., Sastre-Serra, J., Blanquer-Rossello, M. M. et al., Genistein modulates oxidative stress in breast cancer cell lines according to ERalpha/ERbeta ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Int. J. Biochem. Cell Biol. 2013, 45, 2045-2051.
39. Callero, M. A., Loaiza-Perez, A. I., The role of aryl hydrocarbon receptor and crosstalk with estrogen receptor in response of breast cancer cells to the novel antitumor agents benzothiazoles and aminoflavone. Int. J. Breast Cancer 2011, 2011, 923250-923258.
40. Han, E. H., Kim, J. Y., Jeong, H. G., Effect of biochanin A on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Arch. Pharm. Res. 2006, 29, 570-576.
41. Liu, S., Abdelrahim, M., Khan, S., Ariazi, E. et al., Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. Biol. Chem. 2006, 387, 1209-1213.
42. Macpherson, L., Matthews, J., Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor alpha expression in human breast cancer cells. Cancer Lett. 2010, 299, 119-129.
43. Ciolino, H. P., Daschner, P. J., Yeh, G. C., Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J 1999, 340(Pt 3), 715-722.
44. Johnston, S. R., Dowsett, M., Aromatase inhibitors for breast cancer: lessons from the laboratory. Nat. Rev. Cancer 2003, 3, 821-831.
45. Ye, L., Chan, F. L., Chen, S., Leung, L. K., The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice. J. Nutr. Biochem. 2012, 23, 1230-1237.
46. Way, T. D., Lee, H. H., Kao, M. C., Lin, J. K., Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression. Eur. J. Cancer 2004, 40, 2165-2174.
47. Choi, E. J., Kim, G. H. Antiproliferative activity of daidzein and genistein may be related to ERalpha/c-erbB-2 expression in human breast cancer cells. Mol. Med. Rep. 2013, 7, 781-784.
48. Vo, A. T., Millis, R. M., Epigenetics and breast cancers. Obstet. Gynecol. Int. 2012, 2012, 602720-602729.
49. Tian, J., Duan, Y. X., Bei, C. Y., Chen, J., Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7. Horm. Metab. Res. 2013, 45, 593-598.
50. de Souza Rocha, S. P., Breiling, A., Gupta, N., Malekpour, M. et al., Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res. 2010, 70, 9175-9184.
51. Markaverich, B. M., Shoulars, K., Rodriguez, M. A. Luteolin regulation of estrogen signaling and cell cycle pathway genes in MCF-7 human breast cancer cells. Int. J. Biomed. Sci. 2011, 7, 101-111.
52. Ahmad, A., Sarkar, S. H., Bitar, B., Ali, S. et al., Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells. Mol. Cancer Ther. 2012, 11, 2193-2201.
53. Hagiwara, K., Kosaka, N., Yoshioka, Y., Takahashi, R. U. et al., Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity. Sci. Rep. 2012, 2, 314-322.
54. Sun, L. P., Chen, A. L., Hung, H. C., Chien, Y. H. et al., Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J. Agric. Food Chem. 2012, 60, 11748-11758.
55. Kronski, E., Fiori, M. E., Barbieri, O., Astigiano, S. et al., miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol. Oncol. 2014, 8, 581-595.
56. Xiao, X., Shi, D., Liu, L., Wang, J. et al., Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One 2011, 6, e22934.
57. Bosviel, R., Durif, J., Dechelotte, P., Bignon, Y. J. et al., Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines. Br. J. Nutr. 2012, 108, 1187-1193.
58. Berletch, J. B., Liu, C., Love, W. K., Andrews, L. G. et al., Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J. Cell Biochem. 2008, 103, 509-519.
59. Li, Y., Chen, H., Hardy, T. M., Tollefsbol, T. O., Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein. PLoS One 2013, 8, e54369.
60. Du, L., Xie, Z., Wu, L. C., Chiu, M. et al., Reactivation of RASSF1A in breast cancer cells by curcumin. Nutr. Cancer 2012, 64, 1228-1235.
61. Collins, H. M., Abdelghany, M. K., Messmer, M., Yue, B. et al., Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells. BMC Cancer 2013, 13, 37-47.
62. Kang, D. H., Oxidative stress, DNA damage, and breast cancer. AACN Clin. Issues 2002, 13, 540-549.
63. Sporn, M. B., Liby, K. T., NRF2 and cancer: the good, the bad and the importance of context. Nat. Rev. Cancer 2012, 12, 564-571.
64. Chen, B., Zhang, Y., Wang, Y., Rao, J. et al., Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression. J. Steroid Biochem. Mol. Biol. 2014, 143C, 11-18.
65. Lakshmi, A., Subramanian, S., Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats. Biochimie 2014, 99, 96-109.
66. Jayakumar, J. K., Nirmala, P., Praveen Kumar, B. A., Kumar, A. P., Evaluation of protective effect of myricetin, a bioflavonoid in dimethyl benzanthracene-induced breast cancer in female Wistar rats. South Asian J. Cancer 2014, 3, 107-111.
67. Liu, X., Suzuki, N., Santosh Laxmi, Y. R., Okamoto, Y. et al., Anti-breast cancer potential of daidzein in rodents. Life Sci. 2012, 91, 415-419.
68. Singh, B., Shoulson, R., Chatterjee, A., Ronghe, A. et al., Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis 2014, 35, 1872-1880.
69. Li, W., Khor, T. O., Xu, C., Shen, G. et al., Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008, 76, 1485-1489.
70. Yi Lau, G. T., Leung, L. K., The dietary flavonoid apigenin blocks phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in breast cell lines. Food Chem. Toxicol. 2010, 48, 3022-3027.
71. Hsu, J. T., Ying, C., Chen, C. J., Regulation of inducible nitric oxide synthase by dietary phytoestrogen in MCF-7 human mammary cancer cells. Reprod. Nutr. Dev. 2000, 40, 11-18.
72. Vicencio, J. M., Galluzzi, L., Tajeddine, N., Ortiz, C. et al., Senescence, apoptosis or autophagy? When a damaged cell must decide its path-a mini-review. Gerontology 2008, 54, 92-99.
73. Chen, J., Zeng, J., Xin, M., Huang, W. et al., Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm. Metab. Res. 2011, 43, 681-686.
74. Tu, S. H., Ku, C. Y., Ho, C. T., Chen, C. S. et al., Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. Mol. Nutr. Food Res. 2011, 55, 455-466.
75. Tippani, R., Prakhya, L. J., Porika, M., Sirisha, K. et al., Pterostilbene as a potential novel telomerase inhibitor: molecular docking studies and its in vitro evaluation. Curr. Pharm. Biotechnol. 2014, 14, 1027-1035.
76. Chen, C. S., Lee, C. H., Hsieh, C. D., Ho, C. T. et al., Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. Breast Cancer Res. Treat. 2011, 125, 73-87.
77. Way, T. D., Kao, M. C., Lin, J. K., Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 2004, 279, 4479-4489.
78. Reipas, K. M., Law, J. H., Couto, N., Islam, S. et al., Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1). Oncotarget 2013, 4, 329-345.
79. Lee, Y. H., Yuk, H. J., Park, K. H., Bae, Y. S. Coumestrol induces senescence through protein kinase CKII inhibition-mediated reactive oxygen species production in human breast cancer and colon cancer cells. Food Chem. 2013, 141, 381-388.
80. Hendrayani, S. F., Al-Khalaf, H. H., Aboussekhra, A. Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects. Neoplasia 2013, 15, 631-640.
81. Li, X., Xie, W., Xie, C., Huang, C. et al., Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation. Phytother. Res. 2014, 28, 1553-1560.
82. de, L. R., Neefjes, J., Michalides, R., A role for estrogen receptor phosphorylation in the resistance to tamoxifen. Int. J. Breast Cancer 2011, 2011, 232435-232444.
83. Moreira, L., Araujo, I., Costa, T., Correia-Branco, A. et al., Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Exp. Cell Res. 2013, 319, 1784-1795.
84. Gomez, L. S., Zancan, P., Marcondes, M. C., Ramos-Santos, L. et al., Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie 2013, 95, 1336-1343.
85. Yang, B., Huang, J., Xiang, T., Yin, X. et al., Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway. J. Appl. Toxicol. 2014, 34, 105-112.
86. Ko, H. S., Kim, J. S., Cho, S. M., Lee, H. J. et al., Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells. Bioorg. Med. Chem. Lett. 2014, 24, 1176-1179.
87. Song, N. R., Chung, M. Y., Kang, N. J., Seo, S. G. et al., Quercetin suppresses invasion and migration of H-Ras-transformed MCF10A human epithelial cells by inhibiting phosphatidylinositol 3-kinase. Food Chem. 2014, 142, 66-71.
88. Lin, C. W., Hou, W. C., Shen, S. C., Juan, S. H. et al., Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008, 29, 1807-1815.
89. Zhou, R., Xu, L., Ye, M., Liao, M. et al., Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways. Horm. Metab. Res. 2014, 46, 753-760.
90. Pan, M. H., Lin, Y. T., Lin, C. L., Wei, C. S. et al., Suppression of heregulin-beta1/HER2-modulated invasive and aggressive phenotype of breast carcinoma by pterostilbene via inhibition of matrix metalloproteinase-9, p38 kinase cascade and Akt activation. Evid. Based Complement. Alternat. Med. 2011, 2011, 562187-562198.
91. Kim, J. M., Noh, E. M., Kwon, K. B., Kim, J. S. et al., Curcumin suppresses the TPA-induced invasion through inhibition of PKCalpha-dependent MMP-expression in MCF-7 human breast cancer cells. Phytomedicine 2012, 19, 1085-1092.
92. Zong, H., Wang, F., Fan, Q. X., Wang, L. X., Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol. Biol. Rep. 2012, 39, 4803-4808.
93. Sen, T., Moulik, S., Dutta, A., Choudhury, P. R. et al., Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci. 2009, 84, 194-204.
94. Sen, T., Dutta, A., Chatterjee, A., Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drug. 2010, 21, 632-644.
95. Jiang, Y., Xie, K. P., Huo, H. N., Wang, L. M. et al., [Inhibitory effect of luteolin on the angiogenesis of chick chorioallantoic membrane and invasion of breast cancer cells via downregulation of AEG-1 and MMP-2]. Sheng Li Xue Bao 2013, 65, 513-518.
96. Mo, N., Li, Z. Q., Li, J., Cao, Y. D., Curcumin inhibits TGF-beta1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cells. Asian Pac. J. Cancer Prev. 2012, 13, 5709-5714.
97. Huang, T., Chen, Z., Fang, L., Curcumin inhibits LPS-induced EMT through downregulation of NF-kappaB-Snail signaling in breast cancer cells. Oncol. Rep. 2013, 29, 117-124.
98. Charpentier, M. S., Whipple, R. A., Vitolo, M. I., Boggs, A. E. et al., Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res. 2014, 74, 1250-1260.
99. Hong, B. H., Wu, C. H., Yeh, C. T., Yen, G. C., Invadopodia-associated proteins blockade as a novel mechanism for 6-shogaol and pterostilbene to reduce breast cancer cell motility and invasion. Mol. Nutr. Food Res. 2013, 57, 886-895.
100. Sen, T., Chatterjee, A., Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor alpha5beta1 in the process. Eur. J. Nutr. 2011, 50, 465-478.
101. Lee, W. J., Chen, W. K., Wang, C. J., Lin, W. L. et al., Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicol. Appl. Pharmacol. 2008, 226, 178-191.
102. Lee, M. F., Pan, M. H., Chiou, Y. S., Cheng, A. C. et al., Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. J. Agric. Food Chem. 2011, 59, 11853-11861.
103. Magee, P. J., Allsopp, P., Samaletdin, A., Rowland, I. R., Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2. Eur. J. Nutr. 2014, 53, 345-350.
104. Connolly, R., Stearns, V., Epigenetics as a therapeutic target in breast cancer. J. Mammary Gland Biol. Neoplasia 2012, 17, 191-204.
105. Shah, N. R., Chen, H., MicroRNAs in pathogenesis of breast cancer: implications in diagnosis and treatment. World J. Clin. Oncol. 2014, 5, 48-60.